Linical Marks Two Decades of Innovation in Clinical Research and Patient Care
On June 10, 2025, Linical proudly marked its 20-year anniversary, a significant achievement that reflects two decades of unwavering commitment to enhancing health outcomes through patient-focused research. Established in 2005 in Osaka, Japan, Linical has transformed from a modest startup into a leading global player in clinical research services, executing clinical trials across more than 30 countries.
From its inception, Linical aimed higher than simply managing clinical studies. The company's vision was to genuinely impact patients' lives while delivering quality research. Over the years, services have broadened considerably to encompass full-service clinical trial management, site selection, regulatory support, biometrics, pharmacovigilance, and sophisticated drug development strategies. Despite this growth, Linical's mission remains to promote scientific advancements while prioritizing patient safety and well-being.
Kazuhiro Hatano, CEO of Linical, stated, "What began as a small startup with a handful of dedicated professionals from the pharmaceutical industry has evolved into a global force in clinical research. We have always recognized that behind every clinical trial is a patient hoping for a better tomorrow, and this conviction continues to motivate us."
Over the past two decades, Linical has facilitated hundreds of clinical studies spanning various therapeutic domains such as oncology, neurology, immunology, and rare diseases. Utilizing cutting-edge technology and data-driven methodologies, Linical has significantly improved the speed of study initiation, site performance, and overall trial quality. Furthermore, investments in decentralized trial capabilities and digital solutions have positioned the company at the forefront of innovation, particularly during a time when flexibility and accessibility in research are paramount.
Mr. Hatano emphasized the human aspect of clinical research, stating, "It's about the individuals participating in trials, the healthcare providers managing their care, and the sponsors creating new therapies. We take pride in being part of the ecosystem that converts scientific discoveries into tangible benefits for society."
As Linical celebrates this milestone, it eagerly anticipates the future. The rapid integration of artificial intelligence into clinical research presents new opportunities and challenges. Continued investments in global operations, advanced analytics, and patient-centric technologies will further enhance the company's capabilities, enabling them to deliver efficient and high-quality clinical trials that expedite the introduction of innovative therapies.
"While we take pride in our past achievements, we are even more invigorated by the future ahead of us," stated Mr. Hatano. "Our mission to improve lives through research is far from complete."
In summary, Linical’s journey over the past 20 years stands as a testament to its commitment to enhancing clinical research and patient welfare. As it continues to innovate and expand, the company reinforces its dedication to turning scientific research into real-world solutions that improve health and overall quality of life for patients worldwide.
Linical serves as a global provider of clinical research services, assisting biopharmaceutical companies in delivering groundbreaking therapies to patients across regions including APAC, Europe, and North America. With a steadfast focus on quality, technology, and patient care, Linical offers customized solutions for clinical trials across various phases and therapeutic areas.
From its inception, Linical aimed higher than simply managing clinical studies. The company's vision was to genuinely impact patients' lives while delivering quality research. Over the years, services have broadened considerably to encompass full-service clinical trial management, site selection, regulatory support, biometrics, pharmacovigilance, and sophisticated drug development strategies. Despite this growth, Linical's mission remains to promote scientific advancements while prioritizing patient safety and well-being.
Kazuhiro Hatano, CEO of Linical, stated, "What began as a small startup with a handful of dedicated professionals from the pharmaceutical industry has evolved into a global force in clinical research. We have always recognized that behind every clinical trial is a patient hoping for a better tomorrow, and this conviction continues to motivate us."
Over the past two decades, Linical has facilitated hundreds of clinical studies spanning various therapeutic domains such as oncology, neurology, immunology, and rare diseases. Utilizing cutting-edge technology and data-driven methodologies, Linical has significantly improved the speed of study initiation, site performance, and overall trial quality. Furthermore, investments in decentralized trial capabilities and digital solutions have positioned the company at the forefront of innovation, particularly during a time when flexibility and accessibility in research are paramount.
Mr. Hatano emphasized the human aspect of clinical research, stating, "It's about the individuals participating in trials, the healthcare providers managing their care, and the sponsors creating new therapies. We take pride in being part of the ecosystem that converts scientific discoveries into tangible benefits for society."
As Linical celebrates this milestone, it eagerly anticipates the future. The rapid integration of artificial intelligence into clinical research presents new opportunities and challenges. Continued investments in global operations, advanced analytics, and patient-centric technologies will further enhance the company's capabilities, enabling them to deliver efficient and high-quality clinical trials that expedite the introduction of innovative therapies.
"While we take pride in our past achievements, we are even more invigorated by the future ahead of us," stated Mr. Hatano. "Our mission to improve lives through research is far from complete."
In summary, Linical’s journey over the past 20 years stands as a testament to its commitment to enhancing clinical research and patient welfare. As it continues to innovate and expand, the company reinforces its dedication to turning scientific research into real-world solutions that improve health and overall quality of life for patients worldwide.
About Linical
Linical serves as a global provider of clinical research services, assisting biopharmaceutical companies in delivering groundbreaking therapies to patients across regions including APAC, Europe, and North America. With a steadfast focus on quality, technology, and patient care, Linical offers customized solutions for clinical trials across various phases and therapeutic areas.
Topics Health）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.